The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
Open accessAbstract
Neuroblastoma serves as a paradigm for utilising tumour genomic data for determining patient prognosis and treatment allocation. However, before the establishment of the International Neuroblastoma Risk Group (INRG) Task Force in 2004, international consensus on markers, methodology, and data interpretation did not exist, compromising the reliability of decisive genetic markers and inhibiting translational research efforts. The objectives of the INRG Biology Committee were to identify highly prognostic genetic aberrations to be included in the new INRG risk classification schema and to develop precise definitions, decisive biomarkers, and technique standardisation. The review of the INRG database (n=8800 patients) by the INRG Task Force finally enabled the identification of the most significant neuroblastoma biomarkers. In addition, the Biology Committee compared the standard operating procedures of different cooperative groups to arrive at international consensus for methodology, nomenclature, and future directions. Consensus was reached to include MYCN status, 11q23 allelic status, and ploidy in the INRG classification system on the basis of an evidence-based review of the INRG database. Standardised operating procedures for analysing these genetic factors were adopted, and criteria for proper nomenclature were developed. Neuroblastoma treatment planning is highly dependant on tumour cell genomic features, and it is likely that a comprehensive panel of DNA-based biomarkers will be used in future risk assignment algorithms applying genome-wide techniques. Consensus on methodology and interpretation is essential for uniform INRG classification and will greatly facilitate international and cooperative clinical and translational research studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Schouten, J. P. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf056 · Cited by 2,699
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Self-citationNeuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Self-citationAssociation of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
Self-citationThe International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Cohn, S. L., Pearson, A. D. J., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6785 · Cited by 1,910
Self-citationSchwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407
Self-citationThe International Neuroblastoma Pathology Classification (the Shimada system)
Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J.-I., Joshi, V. V., Roald, B., Stram, D. O., Gerbing, R. B., Lukens, J. N., Matthay, K. K., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<364::aid-cncr21>3.0.co;2-7 · Cited by 1,067
Self-citationLook, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. I., & Brodeur, G. M. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.581 · Cited by 594
Self-citationChromosome 1p and 11q Deletions and Outcome in Neuroblastoma
Attiyeh, E. F., London, W. B., Mossé, Y. P., Wang, Q., Winter, C., Khazi, D., McGrady, P. W., Seeger, R. C., Look, A. T., Shimada, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052399 · Cited by 580
Self-citationLook, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., & Green, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110405 · Cited by 491
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma
Caron, H. N., Sluis, P. V., de Kraker, J., Bökkerink, J. P. M., Egeler, M., Laureys, G., Slater, R. M., Westerveld, A., Voûte, P. A., & Versteeg, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340404 · Cited by 425
SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSIS
D'Angio, G., Evans, A., & Koop, C. E. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91606-0 · Cited by 401
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
Janoueix-Lerosey, I., Schleiermacher, G., Michels, E., Mosseri, V., Ribeiro, A., Lequin, D., Vermeulen, J., Couturier, J., Peuchmaur, M., Valent, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0630 · Cited by 349
Self-citationOberthuer, A., Berthold, F., Warnat, P., Hero, B., Kahlert, Y., Spitz, R., Ernestus, K., König, R., Haas, S., Eils, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1879 · Cited by 291
Self-citationSelzer, R. R., Richmond, T. A., Pofahl, N. J., Green, R. D., Eis, P. S., Nair, P., Brothman, A. R., & Stallings, R. L. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20243 · Cited by 266
Asgharzadeh, S., Pique-Regi, R., Sposto, R., Wang, H., Yang, Y., Shimada, H., Matthay, K., Buckley, J., Ortega, A., & Seeger, R. C. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj330 · Cited by 237
Wei, J. S., Greer, B. T., Westermann, F., Steinberg, S. M., Son, C.-G., Chen, Q.-R., Whiteford, C. C., Bilke, S., Krasnoselsky, A. L., Cenacchi, N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0695 · Cited by 182
Self-citationDe Preter, K., Speleman, F., Combaret, V., Lunec, J., Laureys, G., Eussen, B. H. J., Francotte, N., Board, J., Pearson, A. D. J., De Paepe, A., et al. (2002) · Modern Pathology · doi:10.1038/modpathol.3880508 · Cited by 181
Self-citationCaron, H. N. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950240402 · Cited by 175
Spontaneous regression of neuroblastoma.
Evans, A. E., Gerson, J. N., & Schnaufer, L. (1976) · PubMed · Cited by 162
Ohira, M., Oba, S., Nakamura, Y., Isogai, E., Kaneko, S., Nakagawa, A., Hirata, T., Kubo, H., Goto, T., Yamada, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.019 · Cited by 155 · cited 1×
“…shown that genome-wide gene expression profiling can identify differentially expressed transcripts that provide reliable prognostic information (Wei et al, 2004; Ohira et al, 2005; Schramm et al, 2005; Asgharzadeh et al, 2006; Oberthuer et al, 2006; Lastowska et al, 2007; Tomioka et al, 2008).”
BackgroundSelf-citation(1995) · PubMed · Cited by 150
George, R. E., London, W. B., Cohn, S. L., Maris, J. M., Kretschmar, C. S., Diller, L., Brodeur, G. M., Castleberry, R. P., & Look, A. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.582 · Cited by 150
Self-citationAmbros, P. F., & Ambros, I. M. (2001) · Medical and Pediatric Oncology · doi:10.1002/mpo.1242 · Cited by 140
Self-citationQuality Assessment of Genetic Markers Used for Therapy Stratification
Ambros, I. M., Bénard, J., Boavida, M. G., Bown, N. P., Caron, H. N., Combaret, V., Couturier, J., Darnfors, C., Delattre, O., Freeman-Edward, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.025 · Cited by 122
Self-citationStallings, R. L., Nair, P., Maris, J. M., Catchpoole, D. R., McDermott, M., O’Meara, A., & Breatnach, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4154 · Cited by 119
Self-citationSchramm, A. R., Schulte, J. H., Klein‐Hitpaß, L., Havers, W., Sieverts, H., Berwanger, B., Christiansen, H., Warnat, P., Brors, B., Eils, J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208936 · Cited by 117
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
George, R. E., Attiyeh, E. F., Li, S., Moreau, L. A., Neuberg, D. S., Li, C., Fox, E. A., Meyerson, M. M., Diller, L., Fortina, P. M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000255 · Cited by 117
Self-citationMossé, Y. P., Diskin, S. J., Wasserman, N. F., Rinaldi, K., Attiyeh, E. F., Cole, K. A., Jagannathan, J., Bhambhani, K., Winter, C. L., & Maris, J. M. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20477 · Cited by 110
Self-citationŁastowska, M., Viprey, V. F., Santibanez‐Koref, M., Wappler, I., Peters, H., Cullinane, C., Roberts, P., Hall, A. G., Tweddle, D. A., Pearson, A. D. J., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210552 · Cited by 97
Self-citation(SFCE), O. B. O. T. S. F. D. C. D. L., Schleiermacher, G., Michon, J. M., Huon, I., d’Enghien, C. D., Klijanienko, J., Brisse, H. J., Ribeiro, A., Mosseri, V., Rubie, H., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603820 · Cited by 96
Self-citationTomioka, N., Oba, S., Ohira, M., Misra, A., Fridlyand, J., Ishii, S., Nakamura, Y., Isogai, E., Hirata, T., Yoshida, Y., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210661 · Cited by 80
Self-citationSpitz, R., Oberthuer, A., Zapatka, M., Brors, B., Hero, B., Ernestus, K., Oestreich, J., Fischer, M., Simon, T., & Berthold, F. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20376 · Cited by 80
Self-citationThompson, P. M., Maris, J. M., Hogarty, M. D., Seeger, R. C., Reynolds, C. P., Brodeur, G. M., & White, P. S. (2001) · PubMed · Cited by 73
Self-citationManohar, C. F., Salwen, H. R., Brodeur, G. M., & Cohn, S. L. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140307 · Cited by 55
Self-citationWeber, A., Imisch, P., Bergmann, E., & Christiansen, H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.192 · Cited by 46
Bilke, S., Chen, Q., Whiteford, C. C., & Khan, J. I. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bti133 · Cited by 32
Self-citation
Cited by
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.78 · Cited by 1,419
Self-citationAdvances in Risk Classification and Treatment Strategies for Neuroblastoma
Pinto, N. R., Applebaum, M. A., Volchenboum, S. L., Matthay, K. K., London, W. B., Ambros, P. F., Nakagawara, A., Berthold, F., Schleiermacher, G., Park, J. R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4648 · Cited by 911
Self-citationRevised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Irwin, M. S., Naranjo, A., Zhang, F. F., Cohn, S. L., London, W. B., Gastier-Foster, J. M., Ramirez, N. C., Pfau, R., Reshmi, S., Wagner, E., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00278 · Cited by 494
Self-citationIrwin, M. S., & Park, J. R. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2014.09.015 · Cited by 392
Metadata
- Authors
- Ambros, P. F., Ambros, I. M., Brodeur, G. M., Haber, M., Khan, J., Nakagawara, A., Schleiermacher, G., Speleman, F., Spitz, R., London, W. B., Cohn, S. L., Pearson, A. D. J., & Maris, J. M.
- Venue
- British Journal of Cancer
- Published
- 2009-04-28
- Volume
- 100
- Issue
- 9
- Pages
- 1471-1482
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2033037904
- Cited by
- 404
- References
- 40
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.